Abstract
This study was performed to determine whether Boswellic acid suppresses genotoxicity induced by cyclophosphamide in mice. Genotoxicity was induced by the administration of cyclophosphamide (50 mg/kg) in swiss albino mice and was measured by counting the number of micronuclei and observing chromosomal aberration. In test group Boswellic acid was given in the dose of 200 mg/kg and various chromosomal aberration and formation of micronuclei were observed. Boswellic acid in dose of 200 mg/kg significantly (P < 0.001) inhibited the cyclophosphamide induced micronucleus formation and also significantly (P < 0.001) inhibited chromosomal aberrations in mice. Whereas Boswellic acid alone did not either induce formation of micronuclei or chromosomal aberration in mice. Boswellic acid itself doesn’t have any genotoxic effect and suppresses genotoxicity induced by cyclophosphamide.
Similar content being viewed by others
References
Adler ID (1984) Cytogenetic tests in mammals. In: Venitt S, Parry JM (eds) Mutagenicity testing: A practical approach. IRL, Oxford, pp 275–306
Andrade N, Perazzo F, Maistro E (2008) Lack of clastogenic/genotoxic effects of Baccharis dracunculifolia extract on Swiss mouse peripheral blood cells. Genet Mol Res 7:1414–1421
Andraws R, Chawla P, Brown DL (2005) Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis 47:217–225
Bishnoi M, Patil CS, Kumar A, Kulkarni SK (2007) Co administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipooxygenase inhibitor, potentiates protective effect of COX-2 inhibitors in kainic acid induced neurotoxicity in mice. Pharmacol 79:34–41
Brien JO, Renwick A (2006) Approaches to the risk assessment of genotoxic carcinogens in food: A Critical Appraisal. Food and Chem Toxicol 44:1613–1615
Burcham PC (1999) Internal hazards Baseline DNA damage by endogeneous products of normal metabolism. Mutat Res 443:11–36
Cuaz PC, Billiet L, Bauge E, Copin C, Scott AD, Genze F, Buchele B, Syrovets T, Simmet T, Rouis M (2008) Anti inflammatory and anti atherogenic effects of NF-kappa B inhibitor acetyl-11- keto-beta-boswellic acid in LPS-challenged ApoE−/−mice. Arterioscler Thromb Vasc Biol 28:272–277
Ernst E (2002) The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John’s Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136:42–53
Gonçalves da Silva RM, Coelho de Sousa N, Graf U, Spano MA (2008) Antigenotoxic effects of Mandevilla velutina (Gentianales, Apocynaceae) crude extract on cyclophosphamide-induced micronuclei in Swiss mice and urethane-induced somatic mutation and recombination in Drosophila melanogaster. Genet Molec Biol 31:751–758
Hales B (1982) Comparison of the mutagenicity and teratogenicity of Cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard and acrolein. Can Res 42:3016–3021
Hayashi M, Tice RR, MacGregor JT, Anderson D, Blakey DH, Kirsh-Volders M, Oleson FB Jr, Pacchierotti F, Romagna F, Shimada H et al (1994) In vivo rodent erythrocyte micronucleus assay. Mutat Res 312:293–304
Hewitt JB (1997) Health effects of occupational exposure to antineoplastic drugs: An integrative research review, Prepared for the occupational disease panel, Ministry of labour, Canada. 1
Huang MT, Badmaev V, Ding Y, Liu Y, Xie JG, Ho CT (2000) Anti-tumor and anti-carcinogenic activities of triterpenoid, β-boswellic acid. BioFactors 13:225–230
Krishna G, Hyashi M (2000) In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat Res 455:155–166
Krishna G, Petrere J, Anderson J, Theiss J (1995) Use of cyclophosphamide as a positive control in dominant lethal and micronucleus assay. Mutat Res 335:331–337
Lewith GT (2000) Complementary and alternative medicine: an educational, attitudinal and research challenge. Med J Aust 172:102–103
Moore FR, Urda GA, Krishna G, Theiss JC (1995) An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen. 1. Studies with cyclophosphamide. Mutat Res 335:191–199
Prasad S, Naik P, Vijayalaxmi KK (2002) Efficiency of coleus aromaticus extract in modifying cyclophosphamide and mitomycin-c induced clastogenicity in mouse bone marrow cells. Indian J Expt Bio 40:1020–1025
Safayhi H, Mack T, Ammon HP (1999) Protection by Boswellic acids against galactosamine/endotoxin induced hepatitis in mice. Biochem Pharmacol 41:1536–1537
Sánchez-Lamar A, Fuentes JL, Fonseca G, Capiro N, Ferrer M, Alonzo A, Baluja L, Cozzi R, De Salvia R, Fiore M, Llagostera M (2002) Assessment of the potential genotoxic risk of Phyllantus orbicularis HBK aqueous extract using in vitro and in vivo assays. Toxicol Lett 136:87–96
Savage JR (1975) Classification and relationships of induced chromosomal structural changes. J Med Genet 12:103–122
Seyed JH, Mohmmad K (2005) Citrus extract modulates genotoxicity induced by cyclophosphamide in mice bone marrow cells. J Pharm Pharmacol 57:505–509
Sharma ML, Bani S, Singh GB (1989) Antiarthritic activity of Boswellic acids in bovine serum albumin induced arthritis. Int J Immunopharmacol 11:647–652
Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Johri RK, Qazi GN (2008) Gastric ulcer protective effect of boswellic acid, leukotriene inhibitor from boswellia serrata in rat. Phytomedicine 15:408–415
Swierenga SH, Heddle JA, Sigal EA, Gilman JP, Brillinger RL, Douglas GR, Nestmann ER (1991) Recommended protocol based on a survey of current practice in genotoxicity testing laboratories. IV. Chromosome aberrations and sister chromatid exchange in chinese hamster ovary V79 chinese hamster lung and human lymphocytes cultures. Mutat Res 246:301–322
Acknowledgement
Authors are thankful to Council of Scientific and Industrial Research, New Delhi for the fellowship to Kuntal Ganguly (08/558(0001)/2010-EMRI).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ganguly, K., Jagadeesh, N.V., Singh, R. et al. Boswellic acid suppresses cyclophosphamide induced chromosomal damage in mice. Orient Pharm Exp Med 11, 177–181 (2011). https://doi.org/10.1007/s13596-011-0023-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13596-011-0023-5